The E3 ligase ASB3 downregulates antiviral innate immunity by targeting MAVS for ubiquitin-proteasomal degradation

Mingyang Cheng,Yiyuan Lu,Jiarui Wang,Haixu Wang,Yu Sun,Wenhui Zhao,Junhong Wang,Chunwei Shi,Jiawei Luo,Ming Gao,Tianxin Yu,Jianzhong Wang,Jiayao Guan,Nan Wang,Wentao Yang,Yanlong Jiang,Haibin Huang,Guilian Yang,Xin Cao,Dongqin Yang,Chunfeng Wang,Yan Zeng

DOI: https://doi.org/10.1038/s41418-024-01376-5

2024-09-12

Abstract:E3 ubiquitin ligases are very important for regulating antiviral immunity during viral infection. Here, we discovered that Ankyrin repeat and SOCS box-containing protein 3 (ASB3), an E3 ligase, are upregulated in the presence of RNA viruses, particularly influenza A virus (IAV). Notably, overexpression of ASB3 inhibits type I IFN (IFN-I) responses induced by Sendai virus (SeV) and IAV, and ablation of ASB3 restores SeV and H9N2 infection-mediated transcription of IFN-β and its downstream interferon-stimulated genes (ISGs). Interestingly, animals lacking ASB3 presented decreased susceptibility to H9N2 and H1N1 infections. Mechanistically, ASB3 interacts with MAVS and directly mediates K48-linked polyubiquitination and degradation of MAVS at K297, thereby inhibiting the phosphorylation of TBK1 and IRF3 and downregulating downstream antiviral signaling. These findings establish ASB3 as a critical negative regulator that controls the activation of antiviral signaling and describe a novel function of ASB3 that has not been previously reported.